Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CFR Pharmaceuticals SA Threatens To Pull Out Of Adcock Ingram Holdings Ltd's Deal - Reuters


Monday, 11 Nov 2013 07:23am EST 

Reuters reported that CFR Pharmaceuticals SA said on November 11, 2013 it might pull out of a $1.3 billion deal to buy Adcock Ingram Holdings Ltd if it did not win the support of the state pension fund that ranks as Adcock's biggest shareholder. The Public Investment Corporation, which owns 14% of Adcock, said this month the deal was not in its best interests. 

Company Quote

5370.0
-30.0 -0.56%
24 Jul 2014